Phlegm Stasis Clinical Treatment of Hyperlipidemia.doc

 PAGE \* MERGEFORMAT 7 Phlegm Stasis Clinical Treatment of Hyperlipidemia [Abstract] phlegm stasis observed treatment effect in patients with hyperlipidemia, patient admitted to our hospital 76 patients with hyperlipidemia were randomly divided into two groups, treatment group received treatment expectorant circulation control group was treated with lovastatin, continuous treatment of blood lipids were observed after 60d. Results in the treatment group after treatment in patients with TC, TG was significantly lower than before treatment, HDL-C higher than before treatment (P lt;0.05); the control group patients TC was significantly lower than after treatment (P lt;0.05), TG and HDL-C was no significant difference before and after treatment; TG and HDL-C treatment group and the control group significantly after treatment. expectorant Stasis has the effect of lowering blood lipids. [Keywords:] Phlegm stasis; hyperlipidemia; total cholesterol; triglycerides Hyperlipidemia is atherosclerosis and cardiovascular disease risk factors in the main, with the improvement of living standards, changes in diet, increased year by year the incidence of hyperlipidemia, lipid-lowering therapy in the clinic is very important Chinese medicine in the treatment of hyperlipidemia has its unique feature. The author has phlegm stasis treatment of hyperlipidemia in 76 cases, achieve a satisfactory effect, are summarized below. 1 Clinical data 1.1 General Information 76 cases were selected from patients in our hospital from March 2007 to February 2008 cases of out-patient medicine, aged 40 to 70 years, all cases are based on lt;lt;Chinese drug treatment of hyperlipidemia research guidance Policy “gt; [1] diagnostic criteria for diagnosis, rule out the liver, kidney, endocrine diseases and drug-induced hyperlipidemia and nearly 2 weeks to take over other lipid-lowering therapy. selected were randomly divided into two groups, treatment group (expectorant Huayu 40), 23 males